Literature DB >> 17425593

Substrate choice of membrane-type 1 matrix metalloproteinase is dictated by tissue inhibitor of metalloproteinase-2 levels.

Tomoya Kudo1, Takahisa Takino, Hisashi Miyamori, Erik W Thompson, Hiroshi Sato.   

Abstract

Although tissue inhibitor of metalloproteinase-2 (TIMP-2) is known to be not only an inhibitor of matrix metalloproteinases (MMP) but also a cofactor for membrane-type 1 MMP (MT1-MMP)-mediated MMP-2 activation, it is still unclear how TIMP-2 regulates MMP-2 activation and cleavage of substrates by MT1-MMP. In the present study we examined the levels of cell-surface MT1-MMP, MMP-2 activation and cleavage of MT1-MMP substrates in 293T cells transfected with the MT1-MMP and TIMP-2 genes. Co-expression of TIMP-2 at an appropriate level increased the level of cell-surface MT1-MMP, both the TIMP-2-bound and free forms, and generated processed MMP-2 with gelatin-degrading activity. In contrast, MT1-MMP substrates testican-1 and syndecan-1 were cleaved by the cells expressing MT1-MMP, which was inhibited by TIMP-2 even at levels that stimulate MMP-2 activation. These results suggest that TIMP-2 environment determines MT1-MMP substrate choice between direct cleavage of its own substrates and MMP-2 activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17425593     DOI: 10.1111/j.1349-7006.2007.00426.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  17 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

2.  Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis.

Authors:  Michael R Zile; Catalin F Baicu; Robert E Stroud; An Van Laer; Jazmine Arroyo; Rupak Mukherjee; Jeffrey A Jones; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

Review 3.  Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

Authors:  Jie Liu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-10       Impact factor: 3.622

Review 4.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

5.  Extracellular matrix metalloproteinase inducer enhances host resistance against pseudomonas aeruginosa infection through MAPK signaling pathway.

Authors:  Yongwei Li; Lu Chen; Chunxia Wang; Jianshe Chen; Xiaoqian Zhang; Yue Hu; Xiaobin Niu; Dongxu Pei; Zhiqiang He; Yongyi Bi
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

6.  Testican-1 promotes resistance against Pseudomonas aeruginosa-induced keratitis through regulation of MMP-2 expression and activation.

Authors:  Elizabeth A Berger; Sharon A McClellan; Ronald P Barrett; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-18       Impact factor: 4.799

7.  Mechanistic relationship between membrane type-1 matrix metalloproteinase and the myocardial response to pressure overload.

Authors:  Michael R Zile; Catalin F Baicu; Robert E Stroud; An O Van Laer; Jeffrey A Jones; Risha Patel; Rupak Mukherjee; Francis G Spinale
Journal:  Circ Heart Fail       Date:  2014-01-06       Impact factor: 8.790

8.  Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells.

Authors:  Caroline Bret; Dirk Hose; Thierry Reme; Anne-Catherine Sprynski; Karène Mahtouk; Jean-François Schved; Philippe Quittet; Jean-François Rossi; Hartmut Goldschmidt; Bernard Klein
Journal:  Br J Haematol       Date:  2009-03-02       Impact factor: 6.998

9.  Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha.

Authors:  Keita Itatsu; Motoko Sasaki; Junpei Yamaguchi; Shusaku Ohira; Akira Ishikawa; Hiroko Ikeda; Yasunori Sato; Kenichi Harada; Yoh Zen; Hiroshi Sato; Tetsuo Ohta; Masato Nagino; Yuji Nimura; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

Review 10.  Extracellular matrix turnover and outflow resistance.

Authors:  Kate E Keller; Mini Aga; John M Bradley; Mary J Kelley; Ted S Acott
Journal:  Exp Eye Res       Date:  2008-12-06       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.